Chemomab Therapeutics Stock Forecast

Buy candidate since Jun 05, 2026

The Chemomab Therapeutics Ltd. stock price fell by -1.67% on the last day (Friday, 5th Jun 2026) from $1.80 to $1.77. During the last trading day the stock fluctuated 11.32% from a day low at $1.70 to a day high of $1.89. The price has fallen in 6 of the last 10 days and is down by -2.75% for this period. Volume has increased on the last day by 9 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 41 thousand shares were bought and sold for approximately $72.03 thousand.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Chemomab Therapeutics Ltd. stock with a 90% probability to be traded between $1.43 and $2.11 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

CMMB Signals & Forecast

The Chemomab Therapeutics Ltd. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.85. On a fall, the stock will find some support from the long-term average at approximately $1.72. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 2.91%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Chemomab Therapeutics Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Chemomab Therapeutics Ltd. stock

Chemomab Therapeutics Ltd. finds support from accumulated volume at $1.74 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.192 between high and low, or 11.32%. For the last week, the stock has had daily average volatility of 9.99%.

Our recommended stop-loss: $1.70 (-3.87%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (CMMB) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Chemomab Therapeutics Ltd. to open at $1.78, and during the day (based on 14 day Average True Range), to move between $1.70 and $1.84, which gives a possible trading interval of +/-$0.150 (+/-8.84%) up or down from last closing price. If Chemomab Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 8.84% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.74 (1.69%) than the resistance at $1.86 (5.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chemomab Therapeutics Ltd. stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Chemomab Therapeutics Ltd. stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.331 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $1.78 ( 0.787%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk